Positron emission tomography (PET) imaging
Sponsors
Emory University, Johns Hopkins University, NYU Langone Health, Memorial Sloan Kettering Cancer Center, Jonsson Comprehensive Cancer Center
Conditions
AnhedoniaAnorexia NervosaMajor Depressive DisorderMeasure of Uptake of XTRA in the BrainMetastatic CancerNeuroendocrine TumorsPTSDPost-traumatic Stress Disorder (PTSD)
Phase 1
PET Imaging of Extrathalamic α4β2-nicotinic Acetylcholine Receptors in Health and Disease With [18F]XTRA
TerminatedNCT01894646
Start: 2013-02-28End: 2021-06-30Updated: 2022-02-18
18F-MFBG Imaging for Evaluation of Neuroendocrine Malignancies
CompletedNCT02348749
Start: 2015-01-31End: 2025-03-17Updated: 2025-03-19
Imaging of Solid Tumors Using FAP-2286
RecruitingNCT04621435
Start: 2020-12-14End: 2026-12-31Target: 191Updated: 2026-06-04
Application of ⁶⁸Ga-FXX489 (NNS309) PET/CT Imaging in Diagnosis of Tumor Diseases.
RecruitingNCT07144085
Start: 2025-09-11End: 2027-07-30Target: 30Updated: 2026-04-03
Phase 4
Unknown Phase
Kappa Opioid Receptor Imaging in Depression (KOR Depression)
TerminatedNCT02236702
Start: 2014-08-31End: 2016-02-29Updated: 2016-08-17
Kappa Opioid Receptor Imaging in Post-traumatic Stress Disorder (PTSD)
TerminatedNCT02237703
Start: 2012-03-31End: 2016-08-31Updated: 2017-01-20
CB1 Receptor PET Imaging Reveals Gender Differences in PTSD
TerminatedNCT02237677
Start: 2012-06-30End: 2016-03-31Updated: 2016-08-17
Kappa Opioid Receptor Imaging in Anorexia
TerminatedNCT02240797
Start: 2014-09-30End: 2016-03-31Updated: 2016-08-17
Expanded Access Protocol of 68Ga-PSMA-11 for PET Imaging
NCT04348682
Updated: 2021-06-24